Lack of EULAR/ERA-EDTA Response Predicts Chronic Kidney Disease in Patients With Lupus Nephritis
Researchers evaluated EULAR/ERA-EDTA response to therapy in patients with lupus nephritis.
Lupus Nephritis
Belimumab Plus Standard Lupus Nephritis Therapy Improves Renal Responses
Patients with LN who received belimumab in addition to standard therapy experienced a significant 49% decreased risk of renal-related events or death compared with those who received placebo plus standard therapy, a phase 3 study found.
Voclosporin NDA for Lupus Nephritis Submitted to FDA
The New Drug Application (NDA) for voclosporin (Aurinia Pharmaceuticals) has been submitted to the Food and Drug Administration (FDA) for the treatment for lupus nephritis.
Updated EULAR/ERA-EDTA Recommendations for the Management of Lupus Nephritis
The EULAR/ERA-EDTA developed updated recommendations for the management of lupus nephritis.
FDA: Studies Underway to Evaluate Chloroquine for COVID-19
The FDA announced that it is working closely with other government agencies and academic centers to investigate the potential use of chloroquine for the treatment of coronavirus disease 2019 (COVID-19).
Antimalarials May Cut Risk for Type 2 Diabetes in Lupus Patients
T2DM risk reduced by 39 percent for those with high adherence to antimalarial therapy for managing lupus.
Low Income May Increase Risk for Specific Glomerular Diseases
Lower income associated with higher incidence of lupus nephritis, ANCA-related glomerulonephritis.
Renal Arteriosclerosis Develops Prematurely in Lupus Nephritis
A study found that renal arteriosclerosis develops 2 decades earlier in patients with lupus nephritis compared with healthy age-matched controls.
Belimumab Associated With Meaningful Improvement in Lupus Nephritis Trial
GlaxoSmithKline announced positive results from the phase 3 BLISS-LN trial of belimumab for the treatment of active lupus nephritis in adult patients.
Itolizumab Receives Fast Track Status for Lupus Nephritis
The FDA has granted Fast Track designation for itolizumab (EQ001; Equillium) for the treatment of lupus nephritis.
-
Loading...
-
Loading...
Next post in Lupus Nephritis
